DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Domchek SM, Aghajanian C, Shapira-Frommer R. et al.
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy.

Gynecol Oncol 2016;
140: 199-203
DOI: 10.1016/j.ygyno.2015.12.020.

Download Bibliographical Data

Access:
Access: